74 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
technology by the Company's competitors;
the failure of consumers and the medical community to accept the Company's technology as safe and effective;
risks … , the Company's business may fail.
The Company's success depends on the acceptance of its cell replication technology by the medical community
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
by the Company's competitors;
the failure of consumers and the medical community to accept the Company's technology as safe and effective;
risks associated … by the medical community and consumers as a safe and effective solution.
The success of its cell replication technology will depend on its acceptance
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
1994 through 2008, he served in roles as Chief Financial Officer, Chief Compliance Officer and Senior Vice President of Government & Community … 2008, he served in roles as Chief Financial Officer, Chief Compliance Officer and Senior Vice President of Government & Community Relations for Angiotech
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
of the Company's technologies;
the development of superior technology by the Company's competitors;
the failure of consumers and the medical community … , the Company's business may fail.
- 21 -
The Company's success depends on the acceptance of its cell replication technology by the medical community
6-K
EX-99.2
05g bk8xlz
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
20-F/A
fxmos3c
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.2
rsfik m8i
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.4
lkpnp5qwsqme
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.2
yuo2hj5n vdp0y7is7
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.2
xaymqvfp9yp1c9qslo
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
zjy2iltn22d3ap
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
20-F/A
mg51oetfaz
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.3
068cuo
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.2
eplw7d
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm
6-K
EX-99.1
zpl8qmqfi5
13 Nov 20
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.2
x4etcr
15 Oct 20
Condensed Consolidated Interim Financial Statements
5:15pm